Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures

Neurology

Volumn 73, Issue 15, 2009, Pages 1214-1217

  Kurahashi, H ^a,b   Wang, J W ^a,b,c   Ishii, A ^a   Kojima, T ^d   Wakai, S ^e   Kizawa, T ^f   Fujimoto, Y ^g   Kikkawa, K ^h   Yoshimura, K ^a   Inoue, T ^a   Yasumoto, S ^a   Ogawa, A ^a   Kaneko, S ⁱ   Hirose, Shinichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHANDONG UNIVERSITY   (China)

^d RIKEN   (Japan)

^e Nakanoshima Clinic   (Japan)

^f Iwamizawa Municipal General Hospital   (Japan)

^g Niimi Central Hospital   (Japan)

^h Kochi Health Sciences Center   (Japan)

ⁱ HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR ALPHA4; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3;

ADULT; AGED; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FRONTAL LOBE EPILEPSY; GENE DELETION; HUMAN; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; EPILEPSY, BENIGN NEONATAL; FEMALE; HUMANS; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; MALE; MIDDLE AGED; MODELS, GENETIC; PEDIGREE; RECEPTORS, NICOTINIC;

EID: 70350144535     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bc0158     Document Type: Article

References (10)

1. Singh NA, Westenskow P, Charlier C, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003;126:2726-2737.
2. Kanaumi T, Takashima S, Iwasaki H, Itoh M, Mitsudome A, Hirose S. Developmental changes in KCNQ2 and KCNQ3 expression in human brain: possible contribution to the age-dependent etiology of benign familial neonatal convulsions. Brain Dev 2008;30:362-369.
3. Okada M, Zhu G, Hirose S, et al. Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res 2003;53:81-94.
4. Heron SE, Cox K, Grinton BE, et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet 2007;44:791-796.
5. Ishii A, Fukuma G, Uehara A, et al. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev 2009;31:27-33.
6. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11:201-203.
7. De Fusco M, Becchetti A, Patrignani A, et al. The nico-tinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000;26:275-276.
8. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999; 398:805-810.
9. Mulley JC, Nelson P, Guerrero S, et al. A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 2006;67:1094-1095.
10. Madia F, Striano P, Gennaro E, et al. Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology 2006;67:1230-1235.